Document is current
Any future updates will be listed below
-
Authors
He, Emily Y. https://orcid.org/0000-0002-8231-7735
van Hazel, Guy A. https://orcid.org/0000-0001-9717-7993
Sloss, Andrew M.
Pianko, Stephen https://orcid.org/0000-0002-7421-2140
Brown, Gregor J. https://orcid.org/0000-0002-9807-7537
Clingan, Philip R. https://orcid.org/0000-0002-4766-9954
Singh, Rajvinder https://orcid.org/0000-0001-9116-6054
Solterbeck, Ann C. https://orcid.org/0000-0002-0432-0226
Traficante, Robert
Formby-Miller, Louise https://orcid.org/0000-0002-8063-071X
Lockett, Trevor https://orcid.org/0000-0003-4035-9678
Macrae, Finlay
-
Funding
Funding for this research was provided by:
Vision Tech Bio Pty Ltd
- License Information
-
More Information
Article History
Accepted: 7 December 2025
First Online: 16 January 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional Human Research Ethics Committees and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the Central Adelaide Local Health Network Human Research Ethics Committee, Reference No HREC/18/CALHN/534 and endorsed by the Human Research Ethics Committees of the participating study centres.
: Informed consent was obtained from all individual participants included in this study. Bio-banked samples were obtained from participants who had taken part in an ethics-approved clinical trial conducted according to ICH GCP guidelines and provided informed consent, including for their samples to be used for future research.
: Financial: Authors Stephen Pianko and Finlay Macrae have received research funding from Rhythm Diagnostic Systems. Finlay Macrae has also received honoraria from Genetic Technologies Pty Ltd and Glutagen Pty Ltd. Rajvinder Singh has received consulting fees from Olympus (Australia) Pty Ltd and honoraria from Boston Scientific Pty Ltd and Olympus (Australia) Pty Ltd. Ann Solterbeck and Robert Traficante have received consulting fees from Rhythm Biosciences Limited. Louise Formby-Miller and Trevor Lockett are both former employees of Rhythm Biosciences Limited and have stock interests in the company. Trevor Lockett has is also a past member of the Rhythm Biosciences Board and is a consultant to the company. Non-Financial: Finlay Macrae is a Member of the Clinical Advisory Group to the Australian National Bowel Cancer Screening Program. Emily He, Guy van Hazel, Andrew Sloss and Philip Clingan have no relevant financial or non-financial interests to disclose. Emily He, Guy van Hazel, Andrew Sloss and Philip Clingan have no relevant financial or non-financial interests to disclose.
: No material has been reproduced from other sources.
